JP2019524149A5 - - Google Patents

Download PDF

Info

Publication number
JP2019524149A5
JP2019524149A5 JP2019510339A JP2019510339A JP2019524149A5 JP 2019524149 A5 JP2019524149 A5 JP 2019524149A5 JP 2019510339 A JP2019510339 A JP 2019510339A JP 2019510339 A JP2019510339 A JP 2019510339A JP 2019524149 A5 JP2019524149 A5 JP 2019524149A5
Authority
JP
Japan
Prior art keywords
sequence
seq
crispr
cas9 system
snp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019510339A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019524149A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/047861 external-priority patent/WO2018039145A1/en
Publication of JP2019524149A publication Critical patent/JP2019524149A/ja
Publication of JP2019524149A5 publication Critical patent/JP2019524149A5/ja
Priority to JP2021214009A priority Critical patent/JP2022046694A/ja
Priority to JP2024002942A priority patent/JP2024041905A/ja
Pending legal-status Critical Current

Links

JP2019510339A 2016-08-20 2017-08-21 一本鎖ガイドRNA、CRISPR/Cas9システム、及びそれらの使用方法 Pending JP2019524149A (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2021214009A JP2022046694A (ja) 2016-08-20 2021-12-28 一本鎖ガイドRNA、CRISPR/Cas9システム、及びそれらの使用方法
JP2024002942A JP2024041905A (ja) 2016-08-20 2024-01-12 一本鎖ガイドRNA、CRISPR/Cas9システム、及びそれらの使用方法

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201662377586P 2016-08-20 2016-08-20
US62/377,586 2016-08-20
US201762462808P 2017-02-23 2017-02-23
US62/462,808 2017-02-23
US201762501750P 2017-05-05 2017-05-05
US62/501,750 2017-05-05
PCT/US2017/047861 WO2018039145A1 (en) 2016-08-20 2017-08-21 Single guide rna, crispr/cas9 systems, and methods of use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021214009A Division JP2022046694A (ja) 2016-08-20 2021-12-28 一本鎖ガイドRNA、CRISPR/Cas9システム、及びそれらの使用方法

Publications (2)

Publication Number Publication Date
JP2019524149A JP2019524149A (ja) 2019-09-05
JP2019524149A5 true JP2019524149A5 (enExample) 2020-10-01

Family

ID=61246315

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2019510339A Pending JP2019524149A (ja) 2016-08-20 2017-08-21 一本鎖ガイドRNA、CRISPR/Cas9システム、及びそれらの使用方法
JP2021214009A Pending JP2022046694A (ja) 2016-08-20 2021-12-28 一本鎖ガイドRNA、CRISPR/Cas9システム、及びそれらの使用方法
JP2024002942A Pending JP2024041905A (ja) 2016-08-20 2024-01-12 一本鎖ガイドRNA、CRISPR/Cas9システム、及びそれらの使用方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2021214009A Pending JP2022046694A (ja) 2016-08-20 2021-12-28 一本鎖ガイドRNA、CRISPR/Cas9システム、及びそれらの使用方法
JP2024002942A Pending JP2024041905A (ja) 2016-08-20 2024-01-12 一本鎖ガイドRNA、CRISPR/Cas9システム、及びそれらの使用方法

Country Status (6)

Country Link
US (1) US20190185850A1 (enExample)
EP (1) EP3500677A4 (enExample)
JP (3) JP2019524149A (enExample)
KR (2) KR102594051B1 (enExample)
CN (1) CN109963945A (enExample)
WO (1) WO2018039145A1 (enExample)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013066438A2 (en) 2011-07-22 2013-05-10 President And Fellows Of Harvard College Evaluation and improvement of nuclease cleavage specificity
US9828582B2 (en) 2013-03-19 2017-11-28 Duke University Compositions and methods for the induction and tuning of gene expression
US9163284B2 (en) 2013-08-09 2015-10-20 President And Fellows Of Harvard College Methods for identifying a target site of a Cas9 nuclease
US9359599B2 (en) 2013-08-22 2016-06-07 President And Fellows Of Harvard College Engineered transcription activator-like effector (TALE) domains and uses thereof
US9526784B2 (en) 2013-09-06 2016-12-27 President And Fellows Of Harvard College Delivery system for functional nucleases
US9322037B2 (en) 2013-09-06 2016-04-26 President And Fellows Of Harvard College Cas9-FokI fusion proteins and uses thereof
US9340799B2 (en) 2013-09-06 2016-05-17 President And Fellows Of Harvard College MRNA-sensing switchable gRNAs
US20150166984A1 (en) 2013-12-12 2015-06-18 President And Fellows Of Harvard College Methods for correcting alpha-antitrypsin point mutations
AU2015298571B2 (en) 2014-07-30 2020-09-03 President And Fellows Of Harvard College Cas9 proteins including ligand-dependent inteins
US10676726B2 (en) 2015-02-09 2020-06-09 Duke University Compositions and methods for epigenome editing
WO2017070632A2 (en) 2015-10-23 2017-04-27 President And Fellows Of Harvard College Nucleobase editors and uses thereof
EP4036228A1 (en) 2015-11-13 2022-08-03 Avellino Lab USA, Inc. Methods for the treatment of corneal dystrophies
US12214054B2 (en) 2015-11-30 2025-02-04 Duke University Therapeutic targets for the correction of the human dystrophin gene by gene editing and methods of use
EP3443081A4 (en) 2016-04-13 2019-10-30 Duke University CRISPR / CAS9-BASED REPRESSORS FOR IN VIVO SHUT-OFF OF GEN-TARGETS AND METHOD OF USE
JP7490211B2 (ja) 2016-07-19 2024-05-27 デューク ユニバーシティ Cpf1に基づくゲノム編集の治療適用
WO2018027078A1 (en) 2016-08-03 2018-02-08 President And Fellows Of Harard College Adenosine nucleobase editors and uses thereof
AU2017308889B2 (en) 2016-08-09 2023-11-09 President And Fellows Of Harvard College Programmable Cas9-recombinase fusion proteins and uses thereof
WO2020225754A1 (en) * 2019-05-06 2020-11-12 Mcmullen Tara Crispr gene editing for autosomal dominant diseases
EP3500677A4 (en) * 2016-08-20 2020-04-01 Avellino Lab USA, Inc. SINGLE GUIDE RNA, CRISPR / CAS9 SYSTEMS AND METHOD FOR USE THEREOF
WO2020046861A1 (en) * 2018-08-27 2020-03-05 Avellino Lab Usa, Inc. Crispr/cas9 systems, and methods of use thereof
WO2018039438A1 (en) 2016-08-24 2018-03-01 President And Fellows Of Harvard College Incorporation of unnatural amino acids into proteins using base editing
KR20240007715A (ko) 2016-10-14 2024-01-16 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 핵염기 에디터의 aav 전달
WO2018119359A1 (en) 2016-12-23 2018-06-28 President And Fellows Of Harvard College Editing of ccr5 receptor gene to protect against hiv infection
WO2018165504A1 (en) 2017-03-09 2018-09-13 President And Fellows Of Harvard College Suppression of pain by gene editing
KR20190123328A (ko) 2017-03-09 2019-10-31 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 암 백신
CN110914310A (zh) 2017-03-10 2020-03-24 哈佛大学的校长及成员们 胞嘧啶至鸟嘌呤碱基编辑器
IL306092A (en) 2017-03-23 2023-11-01 Harvard College Nucleic base editors that include nucleic acid programmable DNA binding proteins
US11560566B2 (en) 2017-05-12 2023-01-24 President And Fellows Of Harvard College Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation
WO2018225807A1 (ja) * 2017-06-07 2018-12-13 国立大学法人東京大学 顆粒状角膜変性症に対する遺伝子治療薬
EP3658573A1 (en) 2017-07-28 2020-06-03 President and Fellows of Harvard College Methods and compositions for evolving base editors using phage-assisted continuous evolution (pace)
EP3676376B1 (en) 2017-08-30 2025-01-15 President and Fellows of Harvard College High efficiency base editors comprising gam
CA3082251A1 (en) 2017-10-16 2019-04-25 The Broad Institute, Inc. Uses of adenosine base editors
US12406749B2 (en) 2017-12-15 2025-09-02 The Broad Institute, Inc. Systems and methods for predicting repair outcomes in genetic engineering
US12509492B2 (en) 2018-01-19 2025-12-30 Duke University Genome engineering with CRISPR-Cas systems in eukaryotes
US20210032612A1 (en) * 2018-02-22 2021-02-04 Avellino Lab Usa, Inc. CRISPR/Cas9 Systems, and Methods of Use Thereof
JP7550648B2 (ja) * 2018-03-19 2024-09-13 クリスパー セラピューティクス アーゲー 新規rnaプログラム可能エンドヌクレアーゼ系およびその使用
CN112567030A (zh) * 2018-05-08 2021-03-26 勒芬天主教大学 生物传感器
WO2019226953A1 (en) 2018-05-23 2019-11-28 The Broad Institute, Inc. Base editors and uses thereof
EP3820495A4 (en) 2018-07-09 2022-07-20 The Broad Institute Inc. RNA-PROGRAMMABLE EPIGENETIC RNA MODIFIERS AND THEIR USES
WO2020092453A1 (en) 2018-10-29 2020-05-07 The Broad Institute, Inc. Nucleobase editors comprising geocas9 and uses thereof
CA3121191A1 (en) 2018-11-28 2020-06-04 Crispr Therapeutics Ag Optimized mrna encoding cas9 for use in lnps
US12351837B2 (en) 2019-01-23 2025-07-08 The Broad Institute, Inc. Supernegatively charged proteins and uses thereof
WO2020191241A1 (en) 2019-03-19 2020-09-24 The Broad Institute, Inc. Methods and compositions for editing nucleotide sequences
TWI887234B (zh) 2019-04-14 2025-06-21 美國公爵大學 治療杜興氏(duchenne)肌肉失養症之大型突變熱點之aav載體介導之刪除
WO2020214842A1 (en) 2019-04-17 2020-10-22 The Broad Institute, Inc. Adenine base editors with reduced off-target effects
CN110499335B (zh) * 2019-08-08 2023-03-28 复旦大学 CRISPR/SauriCas9基因编辑系统及其应用
CN110551763B (zh) * 2019-08-08 2023-03-10 复旦大学 CRISPR/SlutCas9基因编辑系统及其应用
US12435330B2 (en) 2019-10-10 2025-10-07 The Broad Institute, Inc. Methods and compositions for prime editing RNA
EP4073095A4 (en) * 2019-12-11 2024-11-27 Avellino Lab USA, Inc. Allele-specific silencing of transforming growth factor beta induced gene with r124h mutation using short interfering rna
CA3177481A1 (en) 2020-05-08 2021-11-11 David R. Liu Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence
CN111926015B (zh) * 2020-08-24 2022-07-15 武汉纽福斯生物科技有限公司 寡核苷酸、病毒载体及其应用和RNAi药物制剂
AU2022216614B2 (en) 2021-02-05 2026-03-05 Christiana Care Gene Editing Institute, Inc. Methods of and compositions for reducing gene expression and/or activity
WO2023034704A1 (en) * 2021-08-31 2023-03-09 The Regents Of The University Of California Products and methods for annotating gene function using locally haploid, human non-cancer cells
EP4469577A4 (en) * 2022-01-26 2026-04-15 Orthobio Therapeutics Inc GENE EDITING TO IMPROVE JOINT FUNCTION
WO2023161873A1 (en) * 2022-02-25 2023-08-31 Incisive Genetics, Inc. Gene editing reporter system and guide rna and composition related thereto; composition and method for knocking out dna with more than two grnas; gene editing in the eye; and gene editing using base editors
CN115948537B (zh) * 2022-12-19 2024-04-09 湖南家辉生物技术有限公司 一种基因chst3复合杂合突变的应用及检测试剂和应用
CN116286823B (zh) * 2023-04-04 2026-06-19 上海尧唐生物科技股份有限公司 靶向TGFBI基因的sgRNA、载体及其应用
WO2025043140A1 (en) * 2023-08-23 2025-02-27 Emendobio Inc. Methods and compositions for modifying expression of a mutant transforming growth factor beta induced (tgfbi) allele
CN119464347B (zh) * 2024-11-26 2025-10-03 扬州大学 基于CRISPR-Cas9系统的噬菌体基因组编辑载体及其编辑方法和应用

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946787A (en) 1985-01-07 1990-08-07 Syntex (U.S.A.) Inc. N-(ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US4897355A (en) 1985-01-07 1990-01-30 Syntex (U.S.A.) Inc. N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US5049386A (en) 1985-01-07 1991-09-17 Syntex (U.S.A.) Inc. N-ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)Alk-1-YL-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US9895451B2 (en) 2011-12-02 2018-02-20 Yale University Formulations for targeted release of agents to low pH tissue environments or cellular compartments and methods of use thereof
ES2728782T3 (es) * 2012-05-25 2019-10-28 Univ California Métodos y composiciones para la modificación de ADN objetivo dirigida por ARN y para la modulación de la transcripción dirigida por ARN
EP2890780B8 (en) 2012-08-29 2020-08-19 Sangamo Therapeutics, Inc. Methods and compositions for treatment of a genetic condition
DK3363902T3 (da) * 2012-12-06 2020-01-02 Sigma Aldrich Co Llc Crispr-baseret genommodifikation og -regulering
US8697359B1 (en) 2012-12-12 2014-04-15 The Broad Institute, Inc. CRISPR-Cas systems and methods for altering expression of gene products
CN105209621B (zh) 2012-12-12 2021-05-25 布罗德研究所有限公司 对用于序列操纵的改进的系统、方法和酶组合物进行的工程化和优化
SG10201707569YA (en) 2012-12-12 2017-10-30 Broad Inst Inc Delivery, Engineering and Optimization of Systems, Methods and Compositions for Sequence Manipulation and Therapeutic Applications
EP3064585B1 (en) 2012-12-12 2020-02-05 The Broad Institute, Inc. Engineering and optimization of improved systems, methods and enzyme compositions for sequence manipulation
KR102955556B1 (ko) * 2012-12-12 2026-04-22 더 브로드 인스티튜트, 인코퍼레이티드 서열 조작을 위한 crispr-cas 성분 시스템, 방법 및 조성물
WO2014093694A1 (en) 2012-12-12 2014-06-19 The Broad Institute, Inc. Crispr-cas nickase systems, methods and compositions for sequence manipulation in eukaryotes
PT2931898E (pt) 2012-12-12 2016-06-16 Harvard College Manipulação e otimização de sistemas, métodos e composições para manipulação de sequências com domínios funcionais
EP2931899A1 (en) 2012-12-12 2015-10-21 The Broad Institute, Inc. Functional genomics using crispr-cas systems, compositions, methods, knock out libraries and applications thereof
MX380562B (es) 2012-12-12 2025-03-12 Broad Inst Inc Modificaciones de sistemas, métodos y composiciones guía optimizadas para la manipulación de secuencias.
EP2975117B1 (en) * 2013-03-11 2018-01-10 JCR Pharmaceuticals Co., Ltd. Method for producing human corneal epithelium sheet
EP2997146A4 (en) 2013-05-15 2017-04-26 Sangamo BioSciences, Inc. Methods and compositions for treatment of a genetic condition
ES2777217T3 (es) * 2013-06-17 2020-08-04 Broad Inst Inc Suministro, modificación y optimización de sistemas de guía en tándem, métodos y composiciones para la manipulación de secuencias
KR20260047646A (ko) * 2013-07-09 2026-04-08 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 멀티플렉스 rna-가이드된 게놈 조작
US20150044772A1 (en) * 2013-08-09 2015-02-12 Sage Labs, Inc. Crispr/cas system-based novel fusion protein and its applications in genome editing
US10787684B2 (en) * 2013-11-19 2020-09-29 President And Fellows Of Harvard College Large gene excision and insertion
WO2016049024A2 (en) 2014-09-24 2016-03-31 The Broad Institute Inc. Delivery, use and therapeutic applications of the crispr-cas systems and compositions for modeling competition of multiple cancer mutations in vivo
EP3359662A4 (en) * 2015-10-09 2019-06-19 The Children's Hospital of Philadelphia COMPOSITIONS AND METHODS OF TREATING HUNTINGTON DISEASE AND RELATED DISEASES
EP4036228A1 (en) * 2015-11-13 2022-08-03 Avellino Lab USA, Inc. Methods for the treatment of corneal dystrophies
EP3500677A4 (en) * 2016-08-20 2020-04-01 Avellino Lab USA, Inc. SINGLE GUIDE RNA, CRISPR / CAS9 SYSTEMS AND METHOD FOR USE THEREOF

Similar Documents

Publication Publication Date Title
US20230407341A1 (en) Using Truncated Guide RNAs (tru-gRNAs) to Increase Specificity for RNA-Guided Genome Editing
JP7379447B2 (ja) ゲノム編集分子の細胞内送達のためのペプチドおよびナノ粒子
CN107787367B (zh) 用于crispr/cas介导的基因调控的化学修饰的引导rna
CN108350454B (zh) 等位基因选择性基因编辑及其用途
US12612612B2 (en) Methods for exon skipping and gene knockout using base editors
JP2023113627A (ja) シトシンからグアニンへの塩基編集因子
JP2016537028A5 (enExample)
WO2015115903A1 (en) Site-specific dna break-induced genome editing using engineered nucleases
JP2022546608A5 (enExample)
FI3802807T3 (fi) Rna-ohjattuja nukleaaseja ja niiden aktiivisia fragmentteja ja variantteja ja menetelmiä niiden käyttämiseksi
JP2019522461A5 (enExample)
JP2018527013A5 (enExample)
JP2022545950A5 (enExample)
JP2018518182A5 (enExample)
KR20190090848A (ko) 변형된 가이드 rna
JP2018534950A5 (enExample)
JP2022531347A5 (enExample)
IL302205B2 (en) Rna-guided transcriptional regulation
JP2016501532A5 (enExample)
JP2023511991A5 (enExample)
JP2022023144A5 (enExample)
RU2020100919A (ru) СПОСОБ НОКАУТИРОВАНИЯ ГЕНА-МИШЕНИ В T-КЛЕТКЕ IN VITRO И crRNA, ПРИМЕНЯЕМАЯ В ДАННОМ СПОСОБЕ
ES2285118T5 (es) Un método para el desarrollo molecular in vitro de una función proteica.
WO2023220742A3 (en) Abca4 trans-splicing molecules
Chen et al. Mitochondria isolated from liver contain the essential factors required for RNA/DNA oligonucleotide-targeted gene repair